Home › Compare › TAKD vs JNJ

TAKD vs JNJ: Dividend Comparison 2026

TAKD yields 35087.72% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TAKD wins by $1.4045583093529018e+22M in total portfolio value
10 years
TAKD
TAKD
● Live price
35087.72%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4045583093529018e+22M
Annual income
$13,967,277,210,808,802,000,000,000,000.00
Full TAKD calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TAKD vs JNJ

📍 TAKD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTAKDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TAKD + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TAKD pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TAKD
Annual income on $10K today (after 15% tax)
$2,982,456.14/yr
After 10yr DRIP, annual income (after tax)
$11,872,185,629,187,480,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TAKD beats the other by $11,872,185,629,187,480,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TAKD + JNJ for your $10,000?

TAKD: 50%JNJ: 50%
100% JNJ50/50100% TAKD
Portfolio after 10yr
$7.022791546764509e+21M
Annual income
$6,983,638,605,404,401,000,000,000,000.00/yr
Blended yield
99.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TAKD
No analyst data
Altman Z
-14.6
Piotroski
0/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TAKD buys
0
JNJ buys
0
No recent congressional trades found for TAKD or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTAKDJNJ
Forward yield35087.72% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$1.4045583093529018e+22M$20.0K ✓
Annual income after 10y$13,967,277,210,808,802,000,000,000,000.00 ✓$827.78
Total dividends collected$1.4040435209834525e+22M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TAKD vs JNJ ($10,000, DRIP)

YearTAKD PortfolioTAKD Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$3,519,472$3,508,771.93$10,676$355.77+$3.51M → TAKD
2$1,157,880,257$1,154,114,421.98$11,407$389.39+$1157.87M → TAKD
3$356,094,180,688$354,855,248,813.21$12,198$426.53+$356094.17M → TAKD
4$102,373,625,569,446$101,992,604,796,109.58$13,056$467.62+$102373625.56M → TAKD
5$27,513,170,932,649,252$27,403,631,153,289,944.00$13,987$513.12+$27513170932.64M → TAKD
6$6,912,425,278,424,497,000$6,882,986,185,526,563,000.00$14,998$563.56+$6912425278424.48M → TAKD
7$1,623,550,972,939,442,000,000$1,616,154,677,891,527,600,000.00$16,098$619.52+$1623550972939442.00M → TAKD
8$356,497,181,763,681,700,000,000$354,759,982,222,636,500,000,000.00$17,295$681.69+$356497181763681664.00M → TAKD
9$73,183,067,962,816,976,000,000,000$72,801,615,978,329,840,000,000,000.00$18,599$750.82+$73183067962816978944.00M → TAKD
10$14,045,583,093,529,017,000,000,000,000$13,967,277,210,808,802,000,000,000,000.00$20,022$827.78+$1.4045583093529018e+22M → TAKD

TAKD vs JNJ: Complete Analysis 2026

TAKD — Stock

TransAKT Ltd., through its subsidiary, TransAKT Bio Agritech Ltd., engages in the research and development of agricultural technology. It markets, sells, and distributes indoor agricultural equipment, including lighting, irrigation, and hydroponic growing systems. TransAKT Ltd. has operations primarily in Taiwan, Hong Kong, Mainland China, and Singapore. The company was incorporated in 1996 and is based in Fo Tan, Hong Kong.

Full TAKD Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TAKD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TAKD vs SCHDTAKD vs JEPITAKD vs OTAKD vs KOTAKD vs MAINTAKD vs ABBVTAKD vs MRKTAKD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.